Standard Imaging’s RAy Software reportedly provides all known standard analyses necessary for detailed IMRT QA, patient-specific Cyberknife QA and other frequent QA tasks.

August 29, 2008 - Statins, a group of drugs used to lower cholesterol levels in people with or at risk of having cardiovascular disease, should be used more frequently to combat the adverse cardiovascular outcomes from atherosclerosis, according to new research published in the September 2008 issue of the Journal of Vascular Surgery.

Atherosclerosis (hardening of the arteries) is the leading cause of death of adults worldwide and is caused when fatty substances collect in the inner lining of artery walls.

August 29, 2008 - LUMEDX Corp. and Epiphany Cardiography Products today introduced CardioECG 3.2, a multimodality, multivendor, pure-Web software for cardiac rhythm data management.

August 29, 2008 - The Vascular Medtronic Talent Thoracic Stent Graft System (VALOR) is a safe and effective endovascular therapy, as an alternative to open surgery in patients with thoracic aortic aneurysms who were considered candidates for open surgical repair, according to research published in the September 2008 Journal of Vascular Surgery, published by the Society for Vascular Surgery.

The Cancion System is a heart failure treatment that makes use of Orqis Medical’s continuous aortic flow augmentation (CAFA) technology to improve symptoms of heart failure and change the underlying course of the disease for patients hospitalized for decompensated heart failure who respond inadequately to medical therapy.

Paieon’s CardiOp-B system performs 3D reconstruction in real-time of coronary arteries from standard angiography images.

August 28, 2008 - CoreValve said today an Australia/New Zealand-focused clinical evaluation of its proprietary percutaneous ReValving System, which features a porcine pericardium valve mounted in a self-expanding frame, was initiated last week.

August 28, 2008 – In patients with diabetes, the CYPHER Sirolimus-eluting coronary stent outperformed the Taxus stent with significantly lower rates of in-segment restenosis, target lesion revascularization and major adverse events at nine months, according to clinical data appearing recently in the Journal of the American College of Cardiology.

August 28, 2008 - Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC today launched a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disea

August 28, 2008 - Spectranetics Corp. today announced the first use in Japan of its Spectranetics Laser Sheath (SLS II) technology for removal of cardiac leads.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now